e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
COPD: new markers of diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary and systemic inflammation in patients with AECOPD
S. Liu, Y. Shen, Q. Li, C. Wang (Chongqing, China)
Source:
Annual Congress 2013 –COPD: new markers of diseases
Session:
COPD: new markers of diseases
Session type:
Thematic Poster Session
Number:
603
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Liu, Y. Shen, Q. Li, C. Wang (Chongqing, China). Pulmonary and systemic inflammation in patients with AECOPD. Eur Respir J 2013; 42: Suppl. 57, 603
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014
Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007
Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
The BAL in the bacteriologic etiology in the COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015
Eosinophilia as marker of outcome in hospitalised patients with AECOPD
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Source: Eur Respir J 2007; 29: 906-913
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept